Paper Details

  1. Home
  2. Paper Details

Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.

Author: HambergerB, LjunggrenJ G, LundellG, SääfM, TallstedtL, TaubeA, TörringO, WallinG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A study of 179 patients with Graves' hyperthyroidism compared three treatment options: antithyroid drugs, surgery, and radioiodine treatment. All treatments normalized hormone levels within 6 weeks. Relapse rates were highest in those treated with antithyroid drugs (42% for younger and 34% for older adults), followed by those treated with radioiodine (21%). Surgery resulted in the lowest relapse rates (3% for younger and 8% for older adults). Elevated TSH receptor antibodies increased the risk of relapse regardless of treatment. Ophthalmopathy (eye problems) did not increase the risk of relapse. Overall, patient satisfaction was high for all treatments. The study highlights the importance of considering the risks of ophthalmopathy with radioiodine treatment and the high relapse rate with antithyroid drugs when choosing a treatment for Graves' disease.
Paper Details　
Original Abstract of the Article :
To analyze the benefits and risks of three common treatments, we randomly assigned 179 patients with Graves' hyperthyroidism as follows: 60 patients, 20-34 yr of age (young adults), received antithyroid drugs for 18 months (medical) or subtotal thyroidectomy (surgical), and 119 patients, 35-55 yr of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1210/jcem.81.8.8768863

データ提供：米国国立医学図書館（NLM）

Navigating the Treatment Landscape for Graves' Hyperthyroidism

Graves' hyperthyroidism, a condition characterized by an overactive thyroid, presents clinicians with a challenging decision: which treatment path is best? This study, conducted by the Thyroid Study Group, aimed to compare the effectiveness and safety of three common treatments: antithyroid drugs, surgery, and radioiodine. By randomly assigning 179 patients to different treatment groups, the study offers valuable insights into the nuances of managing Graves' hyperthyroidism. The authors found that all three treatments effectively normalized hormone levels, but the risk of relapse varied significantly among the groups.

Relapse Rates: A Crucial Consideration

The study revealed that antithyroid drugs, despite their effectiveness, led to the highest relapse rates, followed by radioiodine therapy. Surgical treatment demonstrated the lowest relapse rates. These findings underscore the importance of careful patient selection and long-term follow-up. The study also emphasizes the role of TSH receptor antibodies, which can influence the likelihood of relapse. The authors observed that elevated antibody levels at the end of medical therapy, or increasing antibody levels after either medical or surgical treatment, were associated with a greater chance of relapse.

Weighing the Benefits and Risks

This study shines a light on the complexities of treating Graves' hyperthyroidism. While antithyroid drugs are often a first-line option, their relatively high relapse rate necessitates close monitoring. Radioiodine therapy, while effective, may be associated with an increased risk of ophthalmopathy. Surgery, while effective and offering the lowest relapse rate, involves more invasive procedures. The study highlights the need for personalized treatment approaches that consider factors such as age, disease severity, and individual patient preferences.

Dr.Camel's Conclusion

The treatment of Graves' hyperthyroidism is like navigating a treacherous desert landscape. Each path offers a potential solution but comes with its own set of challenges. This study provides a roadmap, guiding clinicians to make informed decisions based on patient needs and the risks associated with each treatment option. The journey to managing Graves' hyperthyroidism requires careful consideration of the terrain and the potential pitfalls along the way.

Date :
  1. Date Completed 1996-12-23
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

8768863

DOI: Digital Object Identifier

10.1210/jcem.81.8.8768863

Related Literature

Article Analysis
・Effective treatment of hyperthyroidism
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.